Sanofi (Exubera) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Sanofi (Exubera) General Information

Description

Worldwide rights of Exubera, an inhaled, dry powder form of human insulin. Exubera is a rapid-acting, dry powder human insulin that is inhaled through the mouth into the lungs prior to eating, using a portable, handheld inhaler.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Frankfurt
  • Germany
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Frankfurt
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanofi (Exubera) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanofi (Exubera)‘s full profile, request access.

Request a free trial

Sanofi (Exubera) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sanofi (Exubera)‘s full profile, request access.

Request a free trial

Sanofi (Exubera) FAQs

  • Where is Sanofi (Exubera) headquartered?

    Sanofi (Exubera) is headquartered in Frankfurt, Germany.

  • What industry is Sanofi (Exubera) in?

    Sanofi (Exubera)’s primary industry is Buildings and Property.

  • Is Sanofi (Exubera) a private or public company?

    Sanofi (Exubera) is a Private company.

  • What is the current valuation of Sanofi (Exubera)?

    The current valuation of Sanofi (Exubera) is 00.00.

  • What is Sanofi (Exubera)’s current revenue?

    The current revenue for Sanofi (Exubera) is 000000.

  • Who are Sanofi (Exubera)’s investors?

    Sanofi has invested in Sanofi (Exubera).

  • When was Sanofi (Exubera) acquired?

    Sanofi (Exubera) was acquired on 28-Feb-2006.

  • Who acquired Sanofi (Exubera)?

    Sanofi (Exubera) was acquired by Pfizer.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »